401 related articles for article (PubMed ID: 17599739)
1. Human chorionic gonadotropin prevents Sjögren's syndrome-like exocrinopathy in mice.
Li N; Shigihara T; Tzioufas AG; Notkins AL; Yoon JW; Jun HS
Arthritis Rheum; 2007 Jul; 56(7):2211-5. PubMed ID: 17599739
[TBL] [Abstract][Full Text] [Related]
2. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.
Jonsson MV; Delaleu N; Brokstad KA; Berggreen E; Skarstein K
Arthritis Rheum; 2006 Jul; 54(7):2300-5. PubMed ID: 16802370
[TBL] [Abstract][Full Text] [Related]
3. Salivary gland cytokine expression in NOD and normal BALB/c mice.
Yamano S; Atkinson JC; Baum BJ; Fox PC
Clin Immunol; 1999 Sep; 92(3):265-75. PubMed ID: 10479531
[TBL] [Abstract][Full Text] [Related]
4. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
5. Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy.
Soyfoo MS; De Vriese C; Debaix H; Martin-Martinez MD; Mathieu C; Devuyst O; Steinfeld SD; Delporte C
Arthritis Rheum; 2007 Aug; 56(8):2566-74. PubMed ID: 17665453
[TBL] [Abstract][Full Text] [Related]
6. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
[TBL] [Abstract][Full Text] [Related]
7. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.
Cha S; Brayer J; Gao J; Brown V; Killedar S; Yasunari U; Peck AB
Scand J Immunol; 2004 Dec; 60(6):552-65. PubMed ID: 15584966
[TBL] [Abstract][Full Text] [Related]
8. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247
[TBL] [Abstract][Full Text] [Related]
9. Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome.
Yamachika S; Nanni JM; Nguyen KH; Garces L; Lowry JM; Robinson CP; Brayer J; Oxford GE; da Silveira A; Kerr M; Peck AB; Humphreys-Beher MG
J Rheumatol; 1998 Dec; 25(12):2371-80. PubMed ID: 9858432
[TBL] [Abstract][Full Text] [Related]
10. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune Sjögren's-like lesions in salivary glands of TGF-beta1-deficient mice are inhibited by adhesion-blocking peptides.
McCartney-Francis NL; Mizel DE; Redman RS; Frazier-Jessen M; Panek RB; Kulkarni AB; Ward JM; McCarthy JB; Wahl SM
J Immunol; 1996 Aug; 157(3):1306-12. PubMed ID: 8757639
[TBL] [Abstract][Full Text] [Related]
12. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
Fox RI; Kang HI; Ando D; Abrams J; Pisa E
J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
[TBL] [Abstract][Full Text] [Related]
13. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy.
Brayer J; Lowry J; Cha S; Robinson CP; Yamachika S; Peck AB; Humphreys-Beher MG
J Rheumatol; 2000 Aug; 27(8):1896-904. PubMed ID: 10955330
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of experimental Sjögren's syndrome through immunization with HSP60 and its peptide amino acids 437-460.
Delaleu N; Madureira AC; Immervoll H; Jonsson R
Arthritis Rheum; 2008 Aug; 58(8):2318-28. PubMed ID: 18668586
[TBL] [Abstract][Full Text] [Related]
15. P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjögren's syndrome.
Schrader AM; Camden JM; Weisman GA
Arch Oral Biol; 2005 Jun; 50(6):533-40. PubMed ID: 15848146
[TBL] [Abstract][Full Text] [Related]
16. NOD mice exocrinopathy: towards a neuroimmune link.
Calafat M; Larocca L; Roca V; Pérez Leirós C
Neuroimmunomodulation; 2007; 14(3-4):175-81. PubMed ID: 18073511
[TBL] [Abstract][Full Text] [Related]
17. Use of topical cyclosporin A in a primary Sjögren's syndrome mouse model.
Tsubota K; Saito I; Ishimaru N; Hayashi Y
Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1551-9. PubMed ID: 9699544
[TBL] [Abstract][Full Text] [Related]
18. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
[TBL] [Abstract][Full Text] [Related]
19. The role of fractalkine as an accelerating factor on the autoimmune exocrinopathy in mice.
Tsubota K; Nishiyama T; Mishima K; Inoue H; Doi T; Hattori Y; Kodama T; Higuchi A; Hayashi Y; Saito I
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4753-60. PubMed ID: 19407023
[TBL] [Abstract][Full Text] [Related]
20. A novel NOD-derived murine model of primary Sjögren's syndrome.
Robinson CP; Yamachika S; Bounous DI; Brayer J; Jonsson R; Holmdahl R; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 1998 Jan; 41(1):150-6. PubMed ID: 9433880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]